Adjaye-Gbewonyo, Kafui
Kretchy, Irene Akwo
Baatiema, Leonard
Grijalva-Eternod, Carlos S.
Sanuade, Olutobi Adekunle
Amon, Samuel
Haghparast-Bidgoli, Hassan
Awuah, Raphael Baffour
Lule, Swaib Abubaker
Mensah, Sedzro Kojo
Kushitor, Sandra Boatemaa
Kushitor, Mawuli Komla
Arhinful, Daniel Kojo
Fottrell, Edward
Funding for this research was provided by:
UK Research and Innovation (MR/T029919/1)
UK Research and Innovation (MR/T029919/1)
UK Research and Innovation (MR/T029919/1)
UK Research and Innovation (MR/T029919/1)
UK Research and Innovation (MR/T029919/1)
UK Research and Innovation (MR/T029919/1)
UK Research and Innovation (MR/T029919/1)
UK Research and Innovation (MR/T029919/1)
UK Research and Innovation (MR/T029919/1)
UK Research and Innovation (MR/T029919/1)
UK Research and Innovation (MR/T029919/1)
UK Research and Innovation (MR/T029919/1)
UK Research and Innovation (MR/T029919/1)
UK Research and Innovation (MR/T029919/1)
Article History
Received: 9 June 2024
Accepted: 7 March 2025
First Online: 19 March 2025
Declarations
:
: This research was in compliance with the Declaration of Helsinki. Ethical approval for the CARE Diabetes project was obtained from the Ghana Health Service (GHS-ERC: 017/02/22); Noguchi Memorial Institute for Medical Research Institutional Review Board, University of Ghana (NMIMR-IRB CP 060/21–22); and the Research Ethics Committee at University College London (ID:21541gamas/001). Informed written consent was obtained from each participant prior to conducting the study.
: Not applicable.
: The authors declare no competing interests.